These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysis. Taylor MR; Cole SW; Strom J; Brazauskas R; Baker KS; Phelan R; Buchbinder D; Hamilton B; Schoemans H; Shaw BE; Sharma A; Bhatt NS; Badawy SM; Winestone LE; Preussler JM; Mayo S; Jamani K; Nishihori T; Lee MA; Knight JM Blood Adv; 2023 Nov; 7(22):6830-6838. PubMed ID: 37773924 [TBL] [Abstract][Full Text] [Related]
6. Relative Telomere Length before Hematopoietic Cell Transplantation and Outcome after Unrelated Donor Hematopoietic Cell Transplantation for Acute Leukemia. Wang Y; Wang T; Dagnall C; Haagenson M; Spellman SR; Hicks B; Jones K; Lee SJ; Savage SA; Gadalla SM Biol Blood Marrow Transplant; 2017 Jul; 23(7):1054-1058. PubMed ID: 28389255 [TBL] [Abstract][Full Text] [Related]
7. Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia. Gadalla SM; Wang T; Haagenson M; Spellman SR; Lee SJ; Williams KM; Wong JY; De Vivo I; Savage SA JAMA; 2015 Feb; 313(6):594-602. PubMed ID: 25668263 [TBL] [Abstract][Full Text] [Related]
8. Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B-Cell acute lymphoblastic leukemia. Segal E; Martens M; Wang HL; Brazauskas R; Weisdorf D; Sandmaier BM; Khoury HJ; de Lima M; Saber W Cancer; 2017 Sep; 123(17):3346-3355. PubMed ID: 28452054 [TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group. Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985 [TBL] [Abstract][Full Text] [Related]
10. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation. El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896 [TBL] [Abstract][Full Text] [Related]
11. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation. Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514 [TBL] [Abstract][Full Text] [Related]
12. Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation. Kliman D; Nivison-Smith I; Gottlieb D; Hamad N; Kerridge I; Purtill D; Szer J; Ma D Biol Blood Marrow Transplant; 2020 Sep; 26(9):1711-1718. PubMed ID: 32194285 [TBL] [Abstract][Full Text] [Related]
13. Influence of Killer Immunoglobulin-Like Receptors and Somatic Mutations on Transplant Outcomes in Acute Myeloid Leukemia. Hong S; Rybicki L; Zhang A; Thomas D; Kerr CM; Durrani J; Rainey MA; Mian A; Behera TR; Carraway HE; Nazha A; Mukherjee S; Advani AS; Patel B; Kalaycio M; Bolwell BJ; Hanna R; Gerds AT; Pohlman B; Hamilton BK; Sekeres MA; Majhail NS; Maciejewski JP; Askar M; Sobecks R Transplant Cell Ther; 2021 Nov; 27(11):917.e1-917.e9. PubMed ID: 34380091 [TBL] [Abstract][Full Text] [Related]
14. Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective. Enright H; Davies SM; DeFor T; Shu X; Weisdorf D; Miller W; Ramsay NK; Arthur D; Verfaillie C; Miller J; Kersey J; McGlave P Blood; 1996 Jul; 88(2):714-20. PubMed ID: 8695820 [TBL] [Abstract][Full Text] [Related]
15. Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome. Slade M; DiPersio JF; Westervelt P; Vij R; Schroeder MA; Romee R Biol Blood Marrow Transplant; 2017 Oct; 23(10):1736-1743. PubMed ID: 28688919 [TBL] [Abstract][Full Text] [Related]
16. A modified EBMT risk score and the hematopoietic cell transplantation-specific comorbidity index for pre-transplant risk assessment in adult acute lymphoblastic leukemia. Terwey TH; Hemmati PG; Martus P; Dietz E; Vuong LG; Massenkeil G; Dörken B; Arnold R Haematologica; 2010 May; 95(5):810-8. PubMed ID: 20007143 [TBL] [Abstract][Full Text] [Related]
17. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
18. Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation. Baker KS; Davies SM; Majhail NS; Hassebroek A; Klein JP; Ballen KK; Bigelow CL; Frangoul HA; Hardy CL; Bredeson C; Dehn J; Friedman D; Hahn T; Hale G; Lazarus HM; LeMaistre CF; Loberiza F; Maharaj D; McCarthy P; Setterholm M; Spellman S; Trigg M; Maziarz RT; Switzer G; Lee SJ; Rizzo JD Biol Blood Marrow Transplant; 2009 Dec; 15(12):1543-54. PubMed ID: 19896078 [TBL] [Abstract][Full Text] [Related]
19. An Examination of Cytomegalovirus, Socioeconomic Status, Race, and Ethnicity on Outcomes after Haploidentical Hematopoietic Transplantation. Jeurkar C; Leiby B; Banks J; Leader A; Rudolph S; Mateja G; Rashid SA; Carabasi M; Filicko-O'Hara J; O'Hara W; Wagner JL; Gergis U; Flomenberg N; Grosso D Transplant Cell Ther; 2021 Apr; 27(4):327.e1-327.e11. PubMed ID: 33836876 [TBL] [Abstract][Full Text] [Related]
20. Specific Class I HLA Supertypes but Not HLA Zygosity or Expression Are Associated with Outcomes following HLA-Matched Allogeneic Hematopoietic Cell Transplant: HLA Supertypes Impact Allogeneic HCT Outcomes. Camacho-Bydume C; Wang T; Sees JA; Fernandez-Viña M; Abid MB; Askar M; Beitinjaneh A; Brown V; Castillo P; Chhabra S; Gadalla SM; Hsu JM; Kamoun M; Lazaryan A; Nishihori T; Page K; Schetelig J; Fleischhauer K; Marsh SGE; Paczesny S; Spellman SR; Lee SJ; Hsu KC Transplant Cell Ther; 2021 Feb; 27(2):142.e1-142.e11. PubMed ID: 33053450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]